Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Blood|June 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myelomaJ L Harousseau, M Attal, M Divine, et al.
Blood|July 1, 1988
Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentationM F Bertheas, D Maraninchi, M Lafage, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignanciesM H Gaspard, D Maraninchi, A M Stoppa, et al.
Bone Marrow Transplantation|January 1, 1990
Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remissionD Blaise, M H Gaspard, A M Stoppa, et al.
Bone Marrow Transplantation|August 3, 2004
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantationM Mohty, H de Lavallade, C Faucher, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patientsN Vey, D Blaise, M Lafage, et al.
European Cytokine Network|February 12, 1998
Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantationN Vey, P Viens, C Fossat, et al.
Cytotherapy|June 5, 2002
CD34(+) immunoselected cells for poor graft function following allogeneic BMTM Mohty, C Faucher, C Chabannon, et al.
Bone Marrow Transplantation|February 26, 2008
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myelomaH de Lavallade, J El-Cheikh, C Faucher, et al.
British Journal of Cancer|March 1, 1992
Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone marrow transplantationB Richard, M C Launay-Iliadis, A Iliadis, et al.
Pageof 12